Click here to get full coverage on Revolve Wealth Partners LLC Sells 12,066 Shares of Amgen Inc. $AMGN - MarketBeat

Revolve Wealth Partners LLC Sells 12,066 Shares of Amgen Inc. $AMGN  MarketBeat

Revolve Wealth Partners LLC Sells 12,066 Shares of Amgen Inc. $AMGN - MarketBeat

Click here to get full coverage on HSBC turns more bullish on Amgen (AMGN) into 2026 - MSN

HSBC turns more bullish on Amgen (AMGN) into 2026  MSN

HSBC turns more bullish on Amgen (AMGN) into 2026 - MSN

Click here to get full coverage on AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS - PR Newswire

AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS  PR Newswire

AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS - PR Newswire

Click here to get full coverage on Amgen Inc.'s (NASDAQ:AMGN) Intrinsic Value Is Potentially 68% Above Its Share Price - Yahoo Finance

Amgen Inc.'s (NASDAQ:AMGN) Intrinsic Value Is Potentially 68% Above Its Share Price  Yahoo Finance

Amgen Inc.'s (NASDAQ:AMGN) Intrinsic Value Is Potentially 68% Above Its Share Price - Yahoo Finance

Click here to get full coverage on Amgen Stock After Hours (AMGN) on Dec. 22, 2025: FDA Clears New Prolia/Xgeva Biosimilars, Fitch Upgrades Credit — What to Know Before the Dec. 23 Open - ts2.tech

Amgen Stock After Hours (AMGN) on Dec. 22, 2025: FDA Clears New Prolia/Xgeva Biosimilars, Fitch Upgrades Credit — What to Know Before the Dec. 23 Open  ts2.tech

Amgen Stock After Hours (AMGN) on Dec. 22, 2025: FDA Clears New Prolia/Xgeva Biosimilars, Fitch Upgrades Credit — What to Know Before the Dec. 23 Open - ts2.tech

Click here to get full coverage on Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice? - The Globe and Mail

Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice?  The Globe and Mail

Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice? - The Globe and Mail

Click here to get full coverage on Is There Still Value in Amgen After Its Strong 2025 Share Price Run? - simplywall.st

Is There Still Value in Amgen After Its Strong 2025 Share Price Run?  simplywall.st

Is There Still Value in Amgen After Its Strong 2025 Share Price Run? - simplywall.st

Click here to get full coverage on Amgen Inc (NASDAQ:AMGN) Nasdaq Index Biotechnology Leadership Focus - Kalkine Media

Amgen Inc (NASDAQ:AMGN) Nasdaq Index Biotechnology Leadership Focus  Kalkine Media

Amgen Inc (NASDAQ:AMGN) Nasdaq Index Biotechnology Leadership Focus - Kalkine Media

Click here to get full coverage on Exchange Traded Concepts LLC Has $17.78 Million Position in Amgen Inc. $AMGN - MarketBeat

Exchange Traded Concepts LLC Has $17.78 Million Position in Amgen Inc. $AMGN  MarketBeat

Exchange Traded Concepts LLC Has $17.78 Million Position in Amgen Inc. $AMGN - MarketBeat

Click here to get full coverage on AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND - PR Newswire

AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND  PR Newswire

AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND - PR Newswire

Click here to get full coverage on Assessing Amgen (AMGN) Valuation After UPLIZNA Approval and New U.S. Drug Pricing Agreements - simplywall.st

Assessing Amgen (AMGN) Valuation After UPLIZNA Approval and New U.S. Drug Pricing Agreements  simplywall.st

Assessing Amgen (AMGN) Valuation After UPLIZNA Approval and New U.S. Drug Pricing Agreements - simplywall.st

Click here to get full coverage on Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025 - ts2.tech

Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025  ts2.tech

Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025 - ts2.tech

Click here to get full coverage on Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock - Yahoo Finance

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock  Yahoo Finance

Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock - Yahoo Finance

Click here to get full coverage on Amgen (AMGN) price target trimmed at Morgan Stanley as policy risks ease - MSN

Amgen (AMGN) price target trimmed at Morgan Stanley as policy risks ease  MSN

Amgen (AMGN) price target trimmed at Morgan Stanley as policy risks ease - MSN

Click here to get full coverage on Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know  Yahoo Finance

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance

Click here to get full coverage on Amgen Stock (AMGN) News Today: TrumpRx Drug-Price Deal, FDA Approvals, Dividend Update, and 2026 Analyst Forecasts - ts2.tech

Amgen Stock (AMGN) News Today: TrumpRx Drug-Price Deal, FDA Approvals, Dividend Update, and 2026 Analyst Forecasts  ts2.tech

Amgen Stock (AMGN) News Today: TrumpRx Drug-Price Deal, FDA Approvals, Dividend Update, and 2026 Analyst Forecasts - ts2.tech

Click here to get full coverage on Matrix Asset Advisors Inc. NY Purchases 4,633 Shares of Amgen Inc. $AMGN - MarketBeat

Matrix Asset Advisors Inc. NY Purchases 4,633 Shares of Amgen Inc. $AMGN  MarketBeat

Matrix Asset Advisors Inc. NY Purchases 4,633 Shares of Amgen Inc. $AMGN - MarketBeat

Click here to get full coverage on Amgen (AMGN) Stock Week Ahead Forecast: Drug-Price Deal Fallout, Analyst Targets, and Year-End Catalysts to Watch (Dec. 22–26, 2025) - ts2.tech

Amgen (AMGN) Stock Week Ahead Forecast: Drug-Price Deal Fallout, Analyst Targets, and Year-End Catalysts to Watch (Dec. 22–26, 2025)  ts2.tech

Amgen (AMGN) Stock Week Ahead Forecast: Drug-Price Deal Fallout, Analyst Targets, and Year-End Catalysts to Watch (Dec. 22–26, 2025) - ts2.tech

Click here to get full coverage on Amgen Inc. (NASDAQ:AMGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Amgen Inc. (NASDAQ:AMGN) Receives Consensus Rating of "Moderate Buy" from Analysts  MarketBeat

Amgen Inc. (NASDAQ:AMGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Click here to get full coverage on Sarasin & Partners LLP Buys 47,873 Shares of Amgen Inc. $AMGN - MarketBeat

Sarasin & Partners LLP Buys 47,873 Shares of Amgen Inc. $AMGN  MarketBeat

Sarasin & Partners LLP Buys 47,873 Shares of Amgen Inc. $AMGN - MarketBeat

Click here to get full coverage on Amgen Inc. $AMGN Shares Sold by CHICAGO TRUST Co NA - MarketBeat

Amgen Inc. $AMGN Shares Sold by CHICAGO TRUST Co NA  MarketBeat

Amgen Inc. $AMGN Shares Sold by CHICAGO TRUST Co NA - MarketBeat

Click here to get full coverage on BMO Capital Lifts Amgen (AMGN) Price Target as MariTide Outlook Strengthens - Yahoo Finance

BMO Capital Lifts Amgen (AMGN) Price Target as MariTide Outlook Strengthens  Yahoo Finance

BMO Capital Lifts Amgen (AMGN) Price Target as MariTide Outlook Strengthens - Yahoo Finance

Click here to get full coverage on Amgen Inc. $AMGN Shares Purchased by Foster Victor Wealth Advisors LLC - MarketBeat

Amgen Inc. $AMGN Shares Purchased by Foster Victor Wealth Advisors LLC  MarketBeat

Amgen Inc. $AMGN Shares Purchased by Foster Victor Wealth Advisors LLC - MarketBeat

Click here to get full coverage on Signal Advisors Wealth LLC Has $867,000 Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Signal Advisors Wealth LLC Has $867,000 Stock Holdings in Amgen Inc. $AMGN  MarketBeat

Signal Advisors Wealth LLC Has $867,000 Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Click here to get full coverage on Amgen (AMGN) Rises As Market Takes a Dip: Key Facts - Yahoo Finance

Amgen (AMGN) Rises As Market Takes a Dip: Key Facts  Yahoo Finance

Amgen (AMGN) Rises As Market Takes a Dip: Key Facts - Yahoo Finance

Click here to get full coverage on Investors in Amgen (NASDAQ:AMGN) have seen decent returns of 76% over the past five years - Yahoo Finance

Investors in Amgen (NASDAQ:AMGN) have seen decent returns of 76% over the past five years  Yahoo Finance

Investors in Amgen (NASDAQ:AMGN) have seen decent returns of 76% over the past five years - Yahoo Finance

Click here to get full coverage on Talbot Financial LLC Purchases 5,839 Shares of Amgen Inc. $AMGN - MarketBeat

Talbot Financial LLC Purchases 5,839 Shares of Amgen Inc. $AMGN  MarketBeat

Talbot Financial LLC Purchases 5,839 Shares of Amgen Inc. $AMGN - MarketBeat

Click here to get full coverage on Voya Investment Management LLC Sells 275,398 Shares of Amgen Inc. $AMGN - MarketBeat

Voya Investment Management LLC Sells 275,398 Shares of Amgen Inc. $AMGN  MarketBeat

Voya Investment Management LLC Sells 275,398 Shares of Amgen Inc. $AMGN - MarketBeat

Click here to get full coverage on Amgen (AMGN) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025 - ts2.tech

Amgen (AMGN) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025  ts2.tech

Amgen (AMGN) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025 - ts2.tech

Click here to get full coverage on Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know - sharewise.com

Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know  sharewise.com

Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know - sharewise.com

Click here to get full coverage on Amgen Inc. $AMGN Stock Holdings Lessened by Assenagon Asset Management S.A. - MarketBeat

Amgen Inc. $AMGN Stock Holdings Lessened by Assenagon Asset Management S.A.  MarketBeat

Amgen Inc. $AMGN Stock Holdings Lessened by Assenagon Asset Management S.A. - MarketBeat

Click here to get full coverage on Czech National Bank Has $38.59 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Czech National Bank Has $38.59 Million Stock Holdings in Amgen Inc. $AMGN  MarketBeat

Czech National Bank Has $38.59 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Click here to get full coverage on $AMGN stock is down 3% today. Here's what we see in our data. - Quiver Quantitative

$AMGN stock is down 3% today. Here's what we see in our data.  Quiver Quantitative

$AMGN stock is down 3% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on AMGN Up Almost 16% in a Month: Should You Buy, Sell or Hold the Stock? - Yahoo Finance

AMGN Up Almost 16% in a Month: Should You Buy, Sell or Hold the Stock?  Yahoo Finance

AMGN Up Almost 16% in a Month: Should You Buy, Sell or Hold the Stock? - Yahoo Finance

Click here to get full coverage on Jim Cramer Says Amgen (AMGN)’s New Drug Has Good Data - Yahoo Finance

Jim Cramer Says Amgen (AMGN)’s New Drug Has Good Data  Yahoo Finance

Jim Cramer Says Amgen (AMGN)’s New Drug Has Good Data - Yahoo Finance

Click here to get full coverage on Goldman Sachs Maintains Price Target on Amgen (AMGN) Before Key Trial Readouts - Yahoo Finance

Goldman Sachs Maintains Price Target on Amgen (AMGN) Before Key Trial Readouts  Yahoo Finance

Goldman Sachs Maintains Price Target on Amgen (AMGN) Before Key Trial Readouts - Yahoo Finance

Click here to get full coverage on Here's How AMGN Benefits From FDA Nod to Uplizna in Myasthenia Gravis - Yahoo Finance

Here's How AMGN Benefits From FDA Nod to Uplizna in Myasthenia Gravis  Yahoo Finance

Here's How AMGN Benefits From FDA Nod to Uplizna in Myasthenia Gravis - Yahoo Finance

Click here to get full coverage on Amgen’s (AMGN) Cholesterol Drug Is Very Important, Says JIm Cramer - Yahoo Finance

Amgen’s (AMGN) Cholesterol Drug Is Very Important, Says JIm Cramer  Yahoo Finance

Amgen’s (AMGN) Cholesterol Drug Is Very Important, Says JIm Cramer - Yahoo Finance

Click here to get full coverage on A Look at Amgen (AMGN) Valuation After Full FDA Approval and NCCN Guideline Update for IMDELLTRA - Yahoo Finance

A Look at Amgen (AMGN) Valuation After Full FDA Approval and NCCN Guideline Update for IMDELLTRA  Yahoo Finance

A Look at Amgen (AMGN) Valuation After Full FDA Approval and NCCN Guideline Update for IMDELLTRA - Yahoo Finance

Click here to get full coverage on Amgen (AMGN) Moves to Reduce Drug Prices in Collaboration with U - GuruFocus

Amgen (AMGN) Moves to Reduce Drug Prices in Collaboration with U  GuruFocus

Amgen (AMGN) Moves to Reduce Drug Prices in Collaboration with U - GuruFocus

Click here to get full coverage on Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline - Yahoo Finance

Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline  Yahoo Finance

Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline - Yahoo Finance

Click here to get full coverage on AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW, STATE-OF-THE-ART CENTER FOR SCIENCE AND INNOVATION AT U.S. GLOBAL HEADQUARTERS - PR Newswire

AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW, STATE-OF-THE-ART CENTER FOR SCIENCE AND INNOVATION AT U.S. GLOBAL HEADQUARTERS  PR Newswire

AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW, STATE-OF-THE-ART CENTER FOR SCIENCE AND INNOVATION AT U.S. GLOBAL HEADQUARTERS - PR Newswire

Click here to get full coverage on Oppenheimer Highlights Amgen’s (AMGN) Strong Revenue Growth and Breakthrough in Cardiovascular Study - Yahoo Finance

Oppenheimer Highlights Amgen’s (AMGN) Strong Revenue Growth and Breakthrough in Cardiovascular Study  Yahoo Finance

Oppenheimer Highlights Amgen’s (AMGN) Strong Revenue Growth and Breakthrough in Cardiovascular Study - Yahoo Finance

Click here to get full coverage on AMGEN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS - PR Newswire

AMGEN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS  PR Newswire

AMGEN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS - PR Newswire

Click here to get full coverage on Amgen (AMGN): Evaluating Valuation After Strong June Performance and Share Price Gains - Yahoo Finance

Amgen (AMGN): Evaluating Valuation After Strong June Performance and Share Price Gains  Yahoo Finance

Amgen (AMGN): Evaluating Valuation After Strong June Performance and Share Price Gains - Yahoo Finance

Click here to get full coverage on Sanders Morris Harris LLC Takes $1.21 Million Position in Amgen Inc. $AMGN - MarketBeat

Sanders Morris Harris LLC Takes $1.21 Million Position in Amgen Inc. $AMGN  MarketBeat

Sanders Morris Harris LLC Takes $1.21 Million Position in Amgen Inc. $AMGN - MarketBeat

Click here to get full coverage on Amgen Inc. $AMGN Shares Sold by Fragasso Financial Advisors Inc - MarketBeat

Amgen Inc. $AMGN Shares Sold by Fragasso Financial Advisors Inc  MarketBeat

Amgen Inc. $AMGN Shares Sold by Fragasso Financial Advisors Inc - MarketBeat

Click here to get full coverage on Amgen's (NASDAQ:AMGN) Shareholders Will Receive A Bigger Dividend Than Last Year - Yahoo Finance

Amgen's (NASDAQ:AMGN) Shareholders Will Receive A Bigger Dividend Than Last Year  Yahoo Finance

Amgen's (NASDAQ:AMGN) Shareholders Will Receive A Bigger Dividend Than Last Year - Yahoo Finance

Click here to get full coverage on Here's How AMGN Benefits From FDA Nod to Uplizna in Myasthenia Gravis - Zacks Investment Research

Here's How AMGN Benefits From FDA Nod to Uplizna in Myasthenia Gravis  Zacks Investment Research

Here's How AMGN Benefits From FDA Nod to Uplizna in Myasthenia Gravis - Zacks Investment Research

Click here to get full coverage on Is Amgen (AMGN) a Safe Bet for Income Investors in Cheap Quarterly Dividend Stocks? - Yahoo Finance

Is Amgen (AMGN) a Safe Bet for Income Investors in Cheap Quarterly Dividend Stocks?  Yahoo Finance

Is Amgen (AMGN) a Safe Bet for Income Investors in Cheap Quarterly Dividend Stocks? - Yahoo Finance

Click here to get full coverage on Wells Fargo Maintains Amgen (AMGN) Equal-Weight Recommendation - Nasdaq

Wells Fargo Maintains Amgen (AMGN) Equal-Weight Recommendation  Nasdaq

Wells Fargo Maintains Amgen (AMGN) Equal-Weight Recommendation - Nasdaq

Click here to get full coverage on Amgen (AMGN): Examining Valuation After Recent 6% Share Price Rise - Yahoo Finance

Amgen (AMGN): Examining Valuation After Recent 6% Share Price Rise  Yahoo Finance

Amgen (AMGN): Examining Valuation After Recent 6% Share Price Rise - Yahoo Finance

Click here to get full coverage on Understanding Momentum Shifts in (AMGN) - news.stocktradersdaily.com

Understanding Momentum Shifts in (AMGN)  news.stocktradersdaily.com

Understanding Momentum Shifts in (AMGN) - news.stocktradersdaily.com

Click here to get full coverage on AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance - Yahoo Finance

AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance  Yahoo Finance

AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance - Yahoo Finance

Click here to get full coverage on AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. - PR Newswire

AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.  PR Newswire

AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. - PR Newswire

Click here to get full coverage on Here's how AMGN benefits from FDA nod to Uplizna in myasthenia gravis - MSN

Here's how AMGN benefits from FDA nod to Uplizna in myasthenia gravis  MSN

Here's how AMGN benefits from FDA nod to Uplizna in myasthenia gravis - MSN

Click here to get full coverage on Amgen Inc.'s (NASDAQ:AMGN) high institutional ownership speaks for itself as stock continues to impress, up 14% over last week - Yahoo Finance

Amgen Inc.'s (NASDAQ:AMGN) high institutional ownership speaks for itself as stock continues to impress, up 14% over last week  Yahoo Finance

Amgen Inc.'s (NASDAQ:AMGN) high institutional ownership speaks for itself as stock continues to impress, up 14% over last week - Yahoo Finance

Click here to get full coverage on AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play? - Yahoo Finance

AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play?  Yahoo Finance

AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play? - Yahoo Finance

Click here to get full coverage on Amgen (AMGN) Announces Launch of AmgenNow - Yahoo Finance

Amgen (AMGN) Announces Launch of AmgenNow  Yahoo Finance

Amgen (AMGN) Announces Launch of AmgenNow - Yahoo Finance

Click here to get full coverage on Why Amgen (AMGN) is a Top Value Stock for the Long-Term - Yahoo Finance

Why Amgen (AMGN) is a Top Value Stock for the Long-Term  Yahoo Finance

Why Amgen (AMGN) is a Top Value Stock for the Long-Term - Yahoo Finance

Click here to get full coverage on Amgen (AMGN) Stock Near Record Highs on Obesity Drug Hopes – Is It Still a Buy in December 2025? - ts2.tech

Amgen (AMGN) Stock Near Record Highs on Obesity Drug Hopes – Is It Still a Buy in December 2025?  ts2.tech

Amgen (AMGN) Stock Near Record Highs on Obesity Drug Hopes – Is It Still a Buy in December 2025? - ts2.tech

Click here to get full coverage on Bank of America Securities Maintains a Sell Rating on Amgen (AMGN) - Yahoo Finance

Bank of America Securities Maintains a Sell Rating on Amgen (AMGN)  Yahoo Finance

Bank of America Securities Maintains a Sell Rating on Amgen (AMGN) - Yahoo Finance

Click here to get full coverage on William Blair Reiterates a Buy on Amgen Inc (AMGN) - Yahoo Finance

William Blair Reiterates a Buy on Amgen Inc (AMGN)  Yahoo Finance

William Blair Reiterates a Buy on Amgen Inc (AMGN) - Yahoo Finance

Click here to get full coverage on Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $381 - 富途牛牛

Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $381  富途牛牛

Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $381 - 富途牛牛

Click here to get full coverage on New Analyst Forecast: $AMGN Given $325 Price Target - Quiver Quantitative

New Analyst Forecast: $AMGN Given $325 Price Target  Quiver Quantitative

New Analyst Forecast: $AMGN Given $325 Price Target - Quiver Quantitative

Click here to get full coverage on Drug Sector on a High as 9 Drugmakers Strike Drug Pricing Deals - The Globe and Mail

Drug Sector on a High as 9 Drugmakers Strike Drug Pricing Deals  The Globe and Mail

Drug Sector on a High as 9 Drugmakers Strike Drug Pricing Deals - The Globe and Mail

Click here to get full coverage on BMO Capital Maintains Amgen (AMGN) Outperform Recommendation - Nasdaq

BMO Capital Maintains Amgen (AMGN) Outperform Recommendation  Nasdaq

AMGN

Price Chart

Key Statistics

Technicals

About AMGN

Latest News

Revolve Wealth Partners LLC Sells 12,066 Shares of Amgen Inc. $AMGN - MarketBeat

HSBC turns more bullish on Amgen (AMGN) into 2026 - MSN

AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS - PR Newswire

Advanced Charts

Top Gainers

Top Losers